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ABSTRACT
Long interspersed element-1 elements compose on
average one-fifth of mammalian genomes. The
expression and retrotransposition of L1 is restricted
by a number of cellular mechanisms in order to limit
their damage in both germ-line and somatic cells.
L1transcriptionislargelysuppressedinmosttissues,
but L1 mRNA and/or proteins are still detectable in
testes, a number of specific somatic cell types, and
malignancies. Down-regulation of L1 expression via
premature polyadenylation has been found to be a
secondary mechanism of limiting L1 expression.
WedemonstratethatmammalianL1elementscontain
numerousfunctionalsplicedonorandacceptorsites.
Efficient usage of some of these sites results in
extensive and complex splicing of L1. Several splice
variants of both the human and mouse L1 elements
undergo retrotransposition. Some of the spliced
L1mRNAscanpotentiallycontributetoexpressionof
open reading frame 2-related products and therefore
haveimplicationsforthemobilityofSINEsevenifthey
areincompetentforL1retrotransposition.Analysisof
the human EST database revealed that L1 elements
also participate in splicing events with other genes.
SuchcontributionoffunctionalsplicesitesbyL1may
result in disruption of normal gene expression or
formation of alternative mRNA transcripts.
INTRODUCTION
Long interspersed element-1 or LINE-1 (L1) is a non-long
terminal repeat (non-LTR), autonomous retroelement cur-
rently active in mammalian genomes that composes 17 and
20% of the human and mouse genomes, respectively (1,2). L1
inserts in the forward orientation are depleted in genes, prob-
ably due to their deleterious effects on gene expression (3–5).
Even though L1 activity has been detected in somatic cells
(6–9), L1 is believed to undergo preferential expression and
retrotransposition in the germ-line (10,11). Suppression of L1
activity is partly attributed to promoter regulation, either
through tissue-speciﬁc transcription factors (12,13), or
methylation of the L1 promoter that is often released upon
malignant transformation (14–16). L1 expression is also
attenuated via premature polyadenylation at internal poly-
adenylation [poly(A)] sites (17). This mechanism is redundant
and cannot be easily overcome by removal of a few internal
poly(A)signals.Amodelofhindered polymeraseIIelongation
along the A-rich L1 sequence was put forward as an additional
explanation for poor expression through L1 elements (18).
L1 transcription uses an internal RNA pol II promoter to
encode a full-length (FL) L1 bicistronic mRNA that produce
open reading frame (ORF) 1 and 2 proteins that are essential
for retrotransposition (19). This FL transcript is retrotransposi-
tionally competent (20), generating new L1 copies via target-
primed reverse transcription (21). The majority of the 500 000
L1 copies found in mammalian genomes are 50 truncated (1)
and/or rearranged (1,22). Thus, only about 100 human ele-
mentsare capable ofexpressingfull-length RNAthatcodes for
functional ORF1 and ORF2 proteins (23).
The signals necessary for RNA splicing include both cis
elements and trans factors, some of which are more conserved
and well characterized then others. RNA splicing [reviewed in
(24)] involves a splice donor site (SD or 50 splice), a splice
acceptor site (SA or 30 splice) and a conserved cis element
20–50 bp 50 to the SA site. Trans-acting factors include
ﬁve snRNAs (U1, U2, U4, U5 and U6) and at least 150 iden-
tiﬁed proteins that form a functional spliceosome (25). Addi-
tionally, there are exonic and intronic splice enhancers (ESE
and ISE) and silencers (ESS and ISS) that can modulate splice
site usage. A consensus sequence for the most often occurring
50and 30 ESE is G/AAAGAA (26). Deviation from the canon-
ical SD or SA sequences may either lead to exon skipping, or it
may result in the usage of cryptic splice sites in the vicinity.
Both constitutive and alternative splicing are responsible for
the 3-fold increase in protein diversity compared with the
number of protein-encoding genes in humans (27,28) with
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doi:10.1093/nar/gkl02735–65% of human genes undergoing alternative splicing
(27,29). Differential splicing is a tissue-, developmental-
and cancer-speciﬁc process (30).
L1 elements have generally been considered to produce
unspliced mRNA. However, studies on L1 RNA have been
confounded by low expression levels and the detection of
numerous low-molecular weight, L1-related transcripts that
were presumedtobe createdfrom the many truncated genomic
copies incorporated into other transcripts (31). Here we report
that L1 contains multiple predicted SD and SA sites in both
sense and antisense strands of its genome. Some of these sites
are functional and their usage leads to a widespread, complex
splicing patternformostL1transcripts.This processing results
inweakening offull-lengthL1expressionand,likeAlu,exoni-
zation (32), leads to aberrant splicing of genes (5,33,34).
MATERIALS AND METHODS
Cell culture and transfections
NIH 3T3 (ATCC CRL-1658), Ntera2 (ATCC #CRL-1973)
and HeLa (ATCC CCL2) cells were maintained as described
elsewhere (17). MCF7 cells (ATCC #HTB-22) were main-
tained in MEM (Gibco) supplemented with 10% bovine
serum (Gibco), sodium pyruvate, essential and nonessential
amino acids and L-glutamine. Sk-Br-3 cells (ATCC HTB-30)
were maintained in RPMI medium1640 supplemented with
15% fetal bovine serum (Gibco). Human mammary epithelial
(HME) cells (CRL-4010) were maintained in MEBM
(Clonetics) supplemented with MEGM SingleQuots
(Clonetics). Transfections of all cell lines were performed by
Lipofectamine with Plus reagent (Invitrogen) as reported pre-
viously (17). Brieﬂy, two T75 ﬂasks with 4–5 · 10
6 cells were
seeded and transfected with 6 mg of CsCl puriﬁed DNA 18–
20hlater.TotalRNA wasisolated byTRiZolreagent24hpost
transfection (Invitrogen) followed by chloroform extraction
and isopropanol precipitation. Total RNA was poly(A) selec-
ted with poly(A) selection kit (Promega) according to the
manufacturer’s protocol. Poly(A)-selected RNAs were preci-
pitated overnight in isopropanol. Northern blot analysis was
performed as described elsewhere (17). The results of the
northern blot assays were quantiﬁed on a Fuji Phosphorim-
ager. DNA template for the probe was produced by PCR with
the primers that ampliﬁed either LINE-1.3 50-untranslated
region (50-UTR), the second exon of the neo
R cassette, the
intron of the neo
R cassette [as described in (17)], the ﬁrst
100 bp (50UTR100 probe) (50-GGAGCCAAGATGGCCG-
AATAGGAACAGCT-30 and 50-ACCTCAGATGGAAA-
TGCAG-30) or 583–698 bp region (50UTR600 probe)
(50-GCAGTAACCTCTGCAGAC-30 and 50-CCACTTGAG-
GAGGCAG-30) of the 50-UTR. The T7 promoter sequence
was included in the reverse primer of each pair.
Site-directed mutagenesis
The QuikChange Site-Directed Mutagenesis kit
(STRATAGENE) was used to change the position 97 splice
site sequence from T to C at position 99 of L1.3 as described
elsewhere (17). The 1M mutation in the L1neo and L1notag
vectors was the same as published previously (17).
RT–PCR
Total RNA from HeLa or NIH 3T3 cells transfected with
L1notag vector was extracted and poly(A) selected as
described elsewhere (17). First-strand synthesis was per-
formed with 30-UTR( )( 5 0-GGTTAGTTACATATGTA-
TAC-30 and ORF2( )( 5 0-CTGTGTCTTTTAATTGCAGA
ATTTAGTCC-30) primers with an RT–PCR kit (Promega)
according to the manufacturer’s protocol followed by PCR
with 48(+) primer 50-GGAGCCAAGATGGCCGAATAG-
GAACAGCT-30. The 30 end of the ORF2( ) primer is
complementary to the position 2038 and 1359 of L1.3.
PCR products were fractionated on a 1% low-melting
agarose gel. The isolated DNA fragments were sequenced
(TGEN, AZ).
Human EST database search
To identify examples of endogenous L1 expressed sequence
tags (ESTs) that participated in splicing events, NCBI dbEST
was searched via BLAST (blastn, E ¼ 1) (35) with the ﬁrst
210 bp of L1.3 consensus sequence, which encompassed the
position 97 SD site. Matches where the similarity with the L1
consensus discontinued within 3 bp of the 97 SD position were
retained for additional analysis. Candidate splices were sub-
sequently located in the genome using BLAT (36) and
examined for the position and orientation of L1 relative to
the gene or other sequences participating in the splice event.
In addition, sequences were manually examined for the usage
of the 97 bp L1 SD and associated SA site. Finally, in order to
exclude thepossibility thattheputativeL1splice eventwasthe
result of transcription from a genomic sequence that mirrored
the splice form (either due to spurious deletions or previously
retrotransposed spliced RNA), all candidate splices were
checked via BLAST and BLAT for identical contiguous
matches to genomic DNA.
RESULTS
LINE-1 elements contain functional splice sites
The BDGP program (http://www.fruitﬂy.org/seq_tools/splice.
html) predicted numerous 50 and 30 splice sites distributed
throughout the sense strand of both the human L1.3
(L19088) and mouse L1spa (AF016099) elements
(Figure 1A). The same program also predicted multiple SD
and SA sites in the antisense sequence of both elements (data
not shown).
To characterize some of the mRNAs produced by the L1.3
element tagged with the neomycin-resistance (NeoR) cassette
(L1.3Neo) (20,37) (Figure 1B), we used a strand-speciﬁc
probe to the second exon and the intron of the NeoR gene
(Figure 1B and C, lane NeoEx and NeoIN) to detect the
L1 sense strand transcripts. Full-length mRNAs were detected
with, and without, the intron interrupting the NeoR cassette
(Figure1C,bands FL1.3NeoINandFL1.3Neo). Highlyabund-
ant, faster-migrating bands were also detected with both
probes. These bands contained NeoR gene sequences, but
were too small to include much L1.3 sequence. One transcript
did not contain the intron of the NeoR cassette as detected by
the intron-speciﬁc probe for the Neo resistance gene
(Figure 1B and C, SpX) while the slower band contained
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of the SpX and X(IN) products approximately corresponded to
the sizes of the spliced and unspliced NeoR gene, respectively.
The Sp(X) band is only weakly detected by a 50-UTR probe
that is biased towards the 30 end of the 50-UTR (Figure 1B and
C),suggestingthatmuchofthe50-UTRsequenceisnotpresent
in this transcript, possibly due to splicing. To conﬁrm the
identity of these products, we used an upstream primer cor-
responding to the beginning of the L1.3 50-UTR and the down-
stream primer complementary to the beginning of the second
exon of the NeoR gene to perform RT–PCR on poly(A)-
selected RNAs from transfected NIH 3T3 cells (Figure 1D).
Figure1.LINE-1elementscontainmultiplesplicesites.(A)AschematicrepresentationofputativesplicesitesidentifiedbytheBDGPprograminthesensestrandof
humanL1.3andmouseL1spa.Black(SD)andgray(SA)arrows marksplicesitesusinga defaultcutoffvalue of0.4.AsterisksmarkSD andSAsitesthathavebeen
identified as functional based upon sequence analysis of spliced transcripts recovered by RT–PCR or as determined by sequence analysis of spliced products found
re-integrated into the human and mouse genomes. PRO corresponds to the L1 promoter region, ORF1 and ORF2 identify ORFs 1 and 2. (B) A schematic
representation of the L1.3 neomycin-resistance (L1.3Neo) expression cassette. The position and orientation of the NeoR gene are shown by an arrow. Iti s
interrupted by an intron (IN) in the same orientation as the L1 ORFs. The cassette ends in L1.3 and SV40 polyadenylation signals (L1.3pA and SV40pA,
respectively). TheL1.3 portionthat is missing in transcriptsSpX and X(IN) is markedabove the cassette. Sequences below the schematic of the vectordemonstrate
the50 and30 splicesiteswithinvariantGTandAGdinucleotidesshowninlargerfont.Theresultingsequenceofthesplicingeventislistedunderthejunctions.Arrows
above the L1.3 expression cassette (marked 50-UTR, NeoEx and NeoIN) represent positions of the strand-specific RNA probes used for L1 RNA detection. The
arrowsindicatethesenseoftheprobes.Becauseofthelengthofthe50-UTRprobe(900bp)invitrotranscriptionproductsareamixoftruncatedtranscripts,whichare
enrichedforthe30 endoftheL1.350-UTR(solidportionofthearrow).Belowthesequencesisaschematicrepresentationofthespliceproductsgeneratedbetweenthe
L1.3 andthe Neo cassette [SpX(IN)and SpX] and the prematurepolyadenylated, unsplicedL1.3mRNAs(1–3). Solidblack linesrepresent portionsof the L1.3and
Neo cassette sequences included in the transcripts. Dotted lines denote parts that were removed by splicing. (C) Northern blot analysis of poly(A)-selected mRNAs
from NIH 3T3 cells transfected with the L1.3Neo expression vector. Strand-specific probes corresponding to the L1.3 50-UTR (50UTR), second exon of the NeoR
gene (NeoEx) and intron of the NeoR gene (NeoIN) were designed to detect plus-strand mRNAs. Full-length L1.3Neo mRNAs with spliced and unspliced NeoR
introns are marked as FL1.3Neo and FL1.3NeoIN, respectively. Numbers 1 through 3 indicate products of premature polyadenylation (17). Potential splice species
arelabeledasSpX,SpX(IN),‘a3’and‘b3’[‘a’and‘b’denotessplicingevents(Figure2)andanumbercorrespondstothepoly(A)sitesusedtogeneratethe30 endof
thetranscripts].NotethatthemostabundantbandintheNeoExlaneisbarelydetectedwiththe50-UTRprobe(50UTRlane)indicatingthatitcontainsasmallportion
ofL1.3.Invitro-generated50-UTRprobeisnotallfull-lengthandthereforethedetectionisskewedtowardthe30 endofthe50-UTR.Resultsofblottingwiththestrand-
specific probe to the NeoR intron (NeoIN) indicate that SpX(IN) contains the intron while SpX does not. (D) RT–PCR analysis of the L1/NeoR splice junction.
Positions of 48(+) and L1Neo( ) primers are shown in (B). RT(+) and ( ) indicate the presence or absence of RT in the respective RT–PCRs.
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yses of ﬁve independent clones demonstrated that the L1.3
sequence is joined to the sequence of the NeoR gene in the
manner consistent with conserved cis elements of mammalian
splicing (Figure 1B). Thus, L1.3 contains at least one func-
tional SD site that can be utilized with SA sites downstream of
its genome. Both SpX and SpX(IN) bands (Figure 1B) require
full-length transcription of the L1.3 mRNA prior to splicing.
This may represent the primary difference between the levels
of full-length transcripts from the L1.3Neo and L1-notag
(which mimics endogenous L1 elements) constructs [(17)
and Figure 2].
RNA splicing limits production of the full-length
L1 mRNA
To determine whether there are other functional SD and SA
sites in the L1.3 sequence, we probed L1 RNAs with a strand-
speciﬁc RNA probe complementary to the ﬁrst 100 bp of the
L1.3 50-UTR (50UTR100 probe) (Figure 2A and B). If the SD
site in the beginning of the L1.3 50-UTR was utilized for L1
splicing, the 50UTR100 probe would allow quantitative com-
parison of the amounts of prematurely terminated transcripts
versus spliced products. Northern blot analyses with the
50UTR100 probe detected the SpX band for the L1Neo con-
struct and two additional faster-migrating bands (a3 and b3,‘a’
and ‘b’ denote splicing events and the number corresponds to
the poly(A) sites used to generate the 30 end of the transcripts)
for both L1Neo and L1-notag constructs (Figure 2A and B and
Supplementary Figures 1 and 2 that help clarify the nomen-
clature of the complex group of RNA species formed by the
concurrent use of both variable splicing and polyadenylation).
These two smaller bands were consistent with splicing within
L1.3 mRNA and were as abundant as the previously reported
major, prematurely polyadenylated species (17). A strand-
speciﬁc RNA probe complementary to the 600–700 bp region
of the L1.3 50-UTR (50UTR600 probe) did not detect bands
‘a3’ and ‘b3’, conﬁrming the loss of this sequence in these
bands (Figure 2B). To determine which of the predicted splice
Figure 2. L1.3 mRNA undergoes splicing at multiple sites. (A) L1.3Neo splicing. The portions of the L1.3 that are removed in splice products ‘a’ and ‘b’ are
annotated abovethe cartoonof the expressioncassette with splicesite sequenceslisted underneath. Strand-specific 100 bp probes corresponding to positions1–100
(50UTR100)and583–698(50UTR600)oftheL1.3sequenceareshownunderthepromoter (Pro)portionoftheL1.3withthearrowdenotingthesenseoftheprobes.
Strand-specificNeoExprobeisthesameasinFigure1.UnderneaththesequencesisaschematicrepresentationoftheprematurelypolyadenylatedL1mRNAs[1–3,
thataredetectedwithboth50UTR100and50UTR600probesin(B)]andprematurelypolyadenylatedandsplicedtranscripts[a3andb3,thataredetectableonlywith
the 50UTR100 probe in (B)]. Solid black lines represent parts of L1.3 sequence included in the transcripts. Dotted black lines correspond to the L1.3 sequences
removedbysplicing.SpX(IN)andSpXproductsarethesameasinFigure1.(B)Northernblotanalysisofpoly(A)-selectedmRNAsfromNIH3T3cellstransfected
with vectors expressing either L1.3Neo (L1Neo) or only L1.3 sequences (L1.3-notag). The 50UTR100 strand-specific probe detected premature poly(A) products
(bands1through3),aswellasthespliceproductsSpXintheL1.3NeoRNAandthe‘a3’and‘b3’productsfortheL1.3NeoandL1.3-notagconstructs[where‘a’refers
to the splice and 3 to the poly(A) site used to create the transcript]. The SpX, ‘a3’ and ‘b3’ bands were not detected by a strand-specific 50UTR600 probe
complementary to the portion of L1.3 expected to be spliced from these transcripts. FL annotates the full-length L1.3 mRNA. (C) RT–PCR analysis of poly(A)-
selected mRNAs from NIH 3T3 cells transiently transfected with L1.3 expression cassette. The 48(+) forward primer described in Figure 1B and ORF2( ) reverse
primerlocatedin L1 ORF2were used.NotethatORF2primercanalsoanneal atposition1359ofL1.3sequencethereforeproducts ofsplices‘a’ and‘b’aresmaller
than expected when the primer anneals at the position 2038 in ORF2 of L1.3.
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species produced by the L1.3-notag construct in NIH 3T3 cells
with primers located at the beginning of the L1.3 sequence and
at the 50 end of ORF2. Sequence analysis of the bands pro-
duced in this experiment conﬁrmed usage of splices ‘a’ and ‘b’
(Figure 2C and Supplementary Figures 1 and 2) and detected
an additional functional SD site at position 54 of the L1.3
element and ﬁve SA sites (Figures 2C and 1, splice sites
are marked by an asterisk). One of the functional SA sites
is located at position 1837 of the L1.3 sequence. Any mRNA
resulting from the usage of this splice site would completely
lack ORF1 sequence but would have the potential to produce
ORF2 protein.
To determine whether L1.3 splicing detected in NIH 3T3
cells is supported by human cells, the L1.3 expression cassette
was transiently transfected in transformed (HeLa and MCF7)
and normal (HME) human cells. Northern blot analysis of
poly(A)-selected RNAs with the 50UTR100 strand-speciﬁc
RNA probe detected mRNA proﬁles identical to those char-
acterized in the mouse cells (Figure 3A).
To evaluate RNA proﬁles of the endogenous human L1
elements, we performed northern blot analysis of RNAs
extracted from human Ntera2 (38) and Sk-Br-3 cancer cells
that express naturally high levels of L1 elements. The
50UTR100 probe detected RNA species consistent with ‘a’
and ‘b’ splice products detected in transient transfection of
mouse and human cells in both cell types (Figure 3B).
Additional faster-migrating bands that were not detected
in transient transfections were observed in Ntera2 and
Sk-Br-3 cells. These bands are consistent with the expected
heterogeneity of the endogenous L1 elements; they could also
be tissue- or cancer-speciﬁc splice and/or polyadenylation
products.
To identify additional functional splice sites in the human
L1, and to conﬁrm that endogenous L1 elements undergo
splicing, we used a pair of primers located in the beginning
and the end of the L1.3 sequence for RT–PCR analysis of
poly(A)-selected RNAs from NIH 3T3 cells transfected
with the L1.3-notag construct, and endogenous RNAs from
HeLa cells (Figure 4). Although there were some variations
consistent with the expected heterogeneity of endogenous
L1 elements, sequence analysis of some of the bands detected
a common functional SA site at the end of the L1 element
(position 5721) that was used with SD sites in the beginning of
the 50-UTR by both transfected and endogenous L1 elements
(Figure 1A). RT–PCR targeting of other regions of the
L1 sequence produced bands consistent with splicing, suggest-
ing that there are almost certainly many other functional
L1 SD and SA sites (data not shown).
The relationship between splicing and premature
polyadenylation within LINE-1
It has been reported previously that there is competition
among, and between (39–41), different splice sites (42,43)
and poly(A) signals (44). It appears that the L1 sequence is
riddled with both splice and poly(A) sites. To determine the
relationship between these signals, we compared RNA species
produced by the wild type (WT) and mutant of the strongest
functionalinternalpoly(A)site(1M)forbothL1.3NeoandL1-
notag (17). This mutant is biologically relevant because one of
the ‘hot’ L1 elements, AL137845, (23) is lacking this poly(A)
site. We performed a northern blot analysis with the strand-
speciﬁc 50UTR100 probe of RNAs from NIH 3T3 cells trans-
fected with WT and 1M L1.3-notag elements. In the WT
background, splice variants ‘a3’ and ‘b3’ are prematurely
terminated at the strongest poly(A) site at the end of ORF1
(Figure 5A and B). When the strongest poly(A) site is not
Figure 3. Transiently transfected and endogenously expressed L1s undergo
splicinginhumancells.(A)NorthernblotanalysesofRNAspeciesproducedby
the L1.3-notag expression cassette transiently transfected in HeLa, MCF7 and
HME cells. Poly(A)-selected total mRNAs from the cell lines were detected
with the strand-specific RNA probe complementary to the first 100 bp of the
L1.3 50UTR (50UTR100). FL corresponds to the full-length L1.3 element, a3
andb3andc4andb4indicatesplicedandprematurelypolyadenylatedproducts.
Note that spliced mRNAs are detected in both normal (HME) and cancer cells
transfected with L1.3 expression cassette. The star denotes bands with an
uncharacterized combination of splicing and polyadenylation. (B) Northern
blot analyses of RNA species produced by the L1.3-notag expression cassette
transiently transfected in NIH 3T3 cells (Lane 3T3/+L1) or endogenously
expressed human L1s from Ntera2 (Nt.2/End.) and Sk-Br-3 (Sk/End.) cells.
Poly(A)-selectedtotalmRNAsfromthecelllinesweredetectedwiththestrand-
specific RNA probe complementary to the first 100 bp of the L1.3 50UTR
(50UTR100). FL corresponds to the full-length L1.3 element detected in
NIH 3T3 cells or to the endogenous L1s detected in human cell lines. a3
and b3 indicate spliced and prematurely polyadenylated products. Black aster-
isks mark truncated mRNA products in human cells exhibiting similar migra-
tionpatternstothesplicedmRNAsidentifiedinNIH3T3cells.Whiteasterisks
point out truncated mRNA products in Ntera2 and Sk-Br-3 cells that are not
detected in transiently transfected mouse cells. Black horizontal arrows corre-
spond to the position of the size markers.
Figure 4. Endogenous L1 elements expressed in HeLa cells undergo splicing.
RT–PCR analysis of poly(A)-selected RNAs from HeLa cells and L1-notag
transfected NIH 3T3 cells was carried out with 48(+) upstream primer and 30-
UTR( ) downstream primer located in the L1.3 30-UTR. RT(+) and ( ) in-
dicate reactions with and without reverse transcriptase.
1516 Nucleic Acids Research, 2006, Vol. 34, No. 5present in the L1.3 sequence, the 50UTR100 probe detects a
slower-migrating doublet (Figure 5A and B, a4 and b4). This
doublet is consistent with the ‘a’ and ‘b’ splice products util-
izing poly(A) sites (4) located further downstream in the L1.3
sequence (Figure 5A). Additionally, two new products occur
in the 1M mutant for both the WT L1.3 (Figure 5B) and the
L1.3Neo constructs (Figure 5C). The small size of these new
L1-related RNA species and the fact that they are not detected
with the 50UTR600 strand-speciﬁc probe (data not shown) is
consistent with the usage of alternative SA/poly(A) sites and/
oran increase inproductionofthe splice variantsthat aremade
by the WT L1.3 in much lower quantities. It appears that
mutations of functional poly(A) sites result in not only
increased utilization of the poly(A) signals nearby (17) but
alsoinquantitativealterationsintheuseofspeciﬁcsplicesites.
Some human and mouse L1 splice products are
retrotranspositionally active
The 50UTR100 probe also detected a slightly faster-migrating
product than the full-length L1.3 mRNA (Figure 5B and D,
a,bFL). The relative amount of this band increased in the 1M
mutant of L1.3-notag. The 50UTR600 strand-speciﬁc probe
failedtoidentify thea,bFL band,butthe truncated prematurely
polyadenylated product (TRpA) produced by the L1.3DSV40
construct was detected (Figure 3D). The size of the a,bFL
RNA is consistent with either splice ‘a’ and/or ‘b’ that ter-
minated at the poly(A) site at the end of the L1.3 element
(Figure 5A). Splice ‘a’ would result in L1 mRNA containing
both ORFs and could potentially be retrotranspositionally
active. Using a BLAST search with the splice junctions cor-
responding to the splice ‘a’ (Figure 2A), we identiﬁed four
sequences on chromosome #1 (AL031985), #3 (AC093006),
#9 (AL137022) and #11 (AP00560) that were ﬂanked by
target-site duplications, a hallmark of endonuclease-
dependant L1 retrotransposition. Alignment of these
sequences demonstrated that AC093006 belongs to the Ta
family while the others were from older subfamilies (Supple-
mentary Figure 3). Splice ‘b’ would produce a L1 mRNA that
could make a truncated ORF1 protein, by utilizing an in-frame
AUG downstream of the wt translation initiation codon
(Figure 2A). A BLAST search of the human genome with
the sequence corresponding to the splice junction ‘b’ identiﬁed
at least 10 matching hits (Supplementary Table 1). Alignment
Figure 5. TherelationshipbetweenpolyadenylationandsplicingofL1transcripts.(A)AdiagramoftheL1.3-notagconstruct.Diagramsofthemajorsplicevariants
detectedbynorthernblotanalysisofthewildtype(WT)andmutantofthestrongestpoly(A)site(1M)L1.3elementsareshownunderneaththeconstruct.Solidblack
linesrepresentL1.3sequencesincludedintoRNAtranscripts.DottedlinesrepresentregionsofL1.3sequenceremovedbysplicing.Some‘a’and‘b’splicingevents
mayuse poly(A)sites at the end of the L1 genome (a,bFLin WT and 1M elements), whileothers may prematurely terminateat the internal L1 poly(A)signals (‘a3’
and‘b3’intheWTand‘a4’and‘b4’inthe1ML1.3).(B)NorthernblotanalysisoftheWTand1ML1.3-notagconstructstransientlytransfectedinNIH3T3cellswith
50UTR100 and 50UTR600 strand-specific probes. Full-length L1.3 mRNA and spliced L1.3 mRNA terminated at the end of the L1 genome are marked as FL and
a,bFL,respectively.SplicedandprematurelytruncatedmRNAsaremarkedas‘a3’,‘b3’,a4,b4.Thestardenotesbandswithanasyetuncharacterizedcombinationof
splicing and polyadenylation that arise in the 1M mutant. (C) Northern blot analysis of the WT and 1M L1.3Neoconstructs transiently transfected in NIH 3T3cells
with 50UTR100 strand-specific probe. Full-length L1.3Neo mRNA is labeled FL1.3Neo. The splice variant specific to this vector is shown as SpX. Spliced and
prematurelytruncatedmRNAsareidentifiedasdescribedin(B).(D)Northernblotanalysisofthefull-lengthandfaster-migratingL1.3mRNAsproducedbytheWT,
1MandDSV40(L1.3withnopAsiteattheendoftheelement)L1.3constructswith50UTR100and50UTR600strand-specificprobes.TRpAstandsforthetruncated
polyadenylated L1.3 mRNA. Other products are marked as described above.
Nucleic Acids Research, 2006, Vol. 34, No. 5 1517of these sequences demonstrated that one, AL807813, belongs
to the Ta family (Supplementary Figure 4). Additionally, we
detected at least one sequence that matches L1 splice 97–303
on chromosome #20 (HSJ581I13). Because L1 constructs in
which the 50-UTR has been almost completely deleted are
found to retrotranspose highly efﬁciently (20), RNAs that
splice out portions of the 50-UTR would also be expected to
be capable of autonomous retrotransposition. We also
searched the mouse genome with sequences corresponding
to some of the splicing events at the predicted splice sites
in the L1spa element (Figure 1). We found 22 matches to
several of the splicing events predicted to produce retrotrans-
positionally competent L1spa mRNAs (SD sites at positions
27 and 239 and SA sites at 1514, 1597 and 1702 of the L1spa,
Supplementary Table 1 and Supplementary Figures 5–7).
L1 splicing is redundant
TheSDsiteatposition97 oftheL1.3genomeappearstobethe
most commonly used 50 splice site. We introduced a point
mutation that destroyed the conserved GU element of the
splice site (97M construct). Northern blot analysis with the
strand-speciﬁc NeoEx probe detected the SpY band of the size
similar to the size of the SpX band, but much lower intensity,
and almost complete disappearance of the SpX(IN) band
(Figure 6). Detection of the SpY band is consistent with either
the usage of a cryptic splice site near the mutated SD site or
utilization of the SD site at position 54 of the L1 genome. Use
of this SD site would result in production of a transcript of
almost the same size as SpX. Additionally, another major,
smaller band, SpZ, was identiﬁed (Figure 6) consistent with
the usage of one of the cryptic SA sites in the exon 2 of the
NeoR gene (45). Quantitative analysis detected no increase in
the amount of the full-length L1.3 RNA in proportion to the
truncated RNA species between the WT and the 97M splice
mutant elements. The 97M splice mutant retrotransposed at
 60% ofthe efﬁciency of the wild-type element asdetermined
by a retrotransposition assay in HeLa cells. This result was
consistent with a reproducible decrease in the amount of RNA
generated by the 97M splice mutant (Figure 6). The 97 splice
site overlaps with a Runx3-binding site that regulates L1 pro-
moter activity and the mutations we used to silence the splice
site have been shown previously to silence this Runx3 site as
well (13). L1.3Neo contains a CMV promoter, but the L1
promoter is also present and may explain changes in RNA
levels in this mutant. Alteration in the splicing pattern of the
97M splice mutant, however, demonstrates that the removal of
one splice site from the L1.3 sequence results in the more
efﬁcient usage of another splice signal. This compensation
of the L1 splicing process is similar to the previously reported
redundancy of the premature polyadenylation (17).
L1 splice sites are utilized for hybrid splicing with
human genes
L1 insertions into human genes can interfere with normal gene
expression in numerous ways, often leading to a disease
[reviewed in (46)]. Therefore, they are poorly tolerated, par-
ticularly when L1s are inserted in the forward orientation. We
wished to determine whether functional splice sites in the L1
sequence can be utilized in combination with the splice sites of
the human genes in which they insert.Weperformed a BLAST
search (35) of the human EST database with the 210 bp frag-
ment of the beginning of the L1.3 50-UTR. Out of the total
1700 hits, 200 ESTs contained L1 sequence terminating
precisely at the splice site at the position 97 of the L1.3. Of
these ESTs 39 involved clear splicing events between L1 SD
site at position 97 and SA sites of 21 different human genes
(Table 1). Most of the other ESTs identiﬁed had sequence
characteristics of authentic splices, but into sequences other
than known exonic SAs. Identiﬁed splicing events between L1
elements and humangenes came from libraries generated from
different human tissues (bladder, brain, stomach and others)
indicatingthattheprocess isnotlimitedtoanyparticulartissue
type. We hypothesize that the number of identiﬁed ESTs of
L1/gene splicing events is underrepresented due to (i) normal-
ization of the majority of the libraries prior to cDNA synthesis,
(ii) potential instability of the hybrid mRNAs, and (iii) most
likely rapid elimination of the L1 insertion events that signi-
ﬁcantly interfere with the normal gene expression (disease or
potential lethality in utero).
DISCUSSION
Because onlyfull-lengthL1 elementshadbeen seen ascapable
of retrotransposition (20), it had been widely assumed that L1
makes only a single RNA species (31). This was called into
question with the demonstration that the majority of L1
RNAs are truncated by premature polyadenylation (17). Our
current data demonstrate that L1 RNAs are also involved in
extensive RNA splicing that would radically alter the diversity
of expressed RNA forms from these elements, as well as
inﬂuence their impact on gene expression upon genomic
insertion.
Relevance to the L1 life cycle
The presence of extensive and complex splicing of the
L1 mRNA has many potential impacts on the life cycle of
Figure 6. Mutation of one of the splice sites in the L1.3 sequence results in the
more efficient utilization of another splice signal. (A) An illustration of the
major splicing events between either wt L1.3 [marked SpX and X(IN)] or a
mutant of the 97 SD site, 97M, (marked SpY and Z) and the NeoR gene
produced by the L1Neo construct. The dotted lines labeled SpY and SpZ
represent predicted splices corresponding to those bands in the northern blot.
(B) A northern blot analysis of the above depicted constructs with the NeoEx
strand-specific probe.
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translation products (47), RNAs that do not encode both ORFs
would not retrotranspose well and therefore almost all of the
L1 splicing events will result in reduction of retrotransposi-
tion. The potential exceptions are the splices that primarily
remove the 50-UTR sequences (e.g. splices ‘a’ and ‘b’ in
Figure 2A). These splice variants could express both ORFs
and therefore be retrotranspositionally competent. Finding a
number of full-length L1 elements that have inserted in the
genome precisely missing those ‘intronic’ sequences demon-
strates that these spliced mRNAs have undergone retrotrans-
position. Because the splicing events remove most of the
promoter (19), any copies inserted by this mechanism
would be less capable of further retrotransposition.
The products of splicing appear to be similar in quantity to
the abundant premature polyadenylation transcripts. However,
we cannot be sure that all spliced RNAs would have similar
stabilities to the full-length RNAs. In particular, some would
have very poor translational potential and, therefore, they
might be subject to degradation by pathways such as
nonsense-mediated decay (48,49). Thus, our observations
represent a minimum estimate of L1 silencing by splicing.
Whether splicing has any major inﬂuence on L1 retrotrans-
position other than lessening expression is not clear. Between
premature polyadenylation and splicing, we would expect pro-
duction of mRNAs that could translate either ORF1 or ORF2
alone, as well as various truncated versions of these proteins.
Production of the ORF2 protein via splicing is most likely not
requiredforL1retrotranspositionbecauseofthe cispreference
of L1 for its translation products (50). However, it would be
expectedtobesufﬁcienttodriveAluretrotransposition(51).Itis
also possible that some of the other translation products may
servetoeitherassist,orhinder,theL1retrotranspositionprocess.
Although we commonly think of splicing in terms of mRNA
maturation, it is worth considering that L1 must return to the
nucleus in order to be inserted and may be re-exposed to parts
of the splicing apparatus. One observation that supports this
association is that L1 elements commonly fuse during integ-
ration to spliceosome-associated U6 snRNA (52). Such chi-
meras can arise by a template switching mechanism, possibly
facilitated by U6 snRNA being bound to the L1 mRNA
molecule undergoing retrotransposition (52,53).
The genomic impact of L1 splicing
A number of studies have demonstrated that extant Alu ele-
ments contribute to extensive alternative splicing of genes
through a process termed Alu exonization (54). Splice sites
donated by Alu arise from mutations in the sequence of these
elements that create consensus splice sites. In contrast,
L1 elements already contain functional splice sites in their
sequences prior to integration. Our ﬁnding of multiple
examples of splicing events between L1 elements and
human genes in the human EST database is consistent with
several previous reports of genetic defect-causing hybrid spli-
cing between L1 elements in either orientation and nearby
genes in both human and mouse (5,33,34). We believe that
our study is biased against the hybrid splicing events that
severely compromise normal gene expression and splicing
events that result in unstable transcripts. Plausible scenarios
for L1 interference with gene expression include exon skip-
ping via splicing between intronic L1s or an L1 and a SA site
of a gene. These events would result in frame shift/nonsense
mutationsorinproductionofaproteinwithpotentialdominant
mutant function. For example, previously reported splicing
between L1 sequence and estrogen receptor (ER) gene pro-
duces a tumor-speciﬁc transcript encoding a protein that lacks
hormone-binding domain of the normal ER (55). At least one
of the genes in Table 1, GFM1, was reported as utilizing an
alternative promoter to generate an alternative exon 1. This
alternative exon is derived from the L1 promoter region.
Because L1 elements contain splice sites in both the sense
and antisense strands, we would speculate that altered splicing
of genes due to L1 elements inserted in introns could be one of
their major negative impacts. The most commonly occurring
50 and 30 ESE is G/AAAG/AAA (26), suggesting that the
A-rich sense strand of L1 elements may have a potential to
support more efﬁcient splicing. An ESE analysis program that
predicts ESE hexamers (http://genes.mit.edu/burgelab/rescue-
ese/) (26,56) identiﬁed four times as many ESEs in the sense
strand of L1.3 as in the antisense. This suggests that there
might be a difference in the strength of the splice sites of
L1 strands which is consistent with the general ﬁnding that
the limited L1 sequences found in introns are preferentially
locatedin the antisense orientation (3,4). PredictedESEs inthe
A-rich L1 sequence have a potential to inﬂuence the strength
of the SA and SD sites of genes they have inserted. The
presence of functional splice sites in the L1 genome may
also contribute to the previously demonstrated decrease of
transcripts containing L1 fragments (18).
Table 1. dbEST examples of L1 SD (97 bp) participating in splicing
events with adjacent genic sequence
Gene ID Number
of ESTs
Subfamily
a L1 insert
location
Gene SA Number
of exons
b
BNI3PL 2 L1PA2 intron 3 exon 4 6
C14ORF161 1 L1PA2 intron 15 exon 15 26
CYSLTR2 3 L1PA2 50 of gene exon 1
c 1
DOCK3 1 L1PA3 intron 5 exon 6 53
DST 1 L1PA3 intron 1 exon 2 22
FLJ10986 1 L1PA3 intron 3 exon 4 16
FLJ22028 1 L1PA2 50 of gene exon 2 12
FLJ30851 1 L1PA6 50 of gene exon 2 13
FLJ39873 2 L1PA3 50 of gene exon 2 4
GABRR1 3 L1PA2 50 of gene exon 3 10
GFM1 1 L1PA2 50 of gene 50 UTR
c 17
GUCY1B2 2 L1PA6 50 of gene exon 14 16
IGSF11 6 L1PA3 introns 2,3
d exon 3 (7,9)
e
KRTAP4-10 1 L1PA2 50 of gene 50-UTR
c 2
LOC196394 6 L1P-AN intron 1 intron 1
c 7
MS4A5 1 L1PA2 intron 4 30-UTR
c 5
Myosin 1D 2 L1PA2 intron 17 17 21
PDGFRA 1 L1PA3 intron 1 2 20
RGL1 1 L1PA3 intron 1 intron 1
c 18
STIM1 1 L1PA3 intron 2 3 12
TAF9L 1 L1PA4 50 of gene 1 7
Abbreviations: ID—GenBank gene identifier; SA—splice acceptor.
aL1 subfamily assignment was performed with RepeatMasker (www.
repeatmasker.org).
bThenumbersinthelastcolumnofthetablecorrespondtothetotalnumberofthe
exons identified in the gene.
cIndicates that L1 SD spliced to a cryptic SA within the gene region indicated.
dDenotesthepresenceofanL1thatspanstwodifferentintronsduetoaportionof
its sequence being incorporated into an exon.
eIndicates alternative exons numbering based on different splice products.
Nucleic Acids Research, 2006, Vol. 34, No. 5 1519The heterogeneity associated with L1 splicing, and its
potential to negatively impact both the L1 life cycle and
host genes, makes it seem unlikely that most of the splicing
observed evolved for a speciﬁc purpose. We favor the
hypothesis that the A-richness of the L1 coding regions
may contribute to the ability of L1 RNAs to splice. Thus,
the A-richness may be the cause of multiple forms of silencing
of, and by, L1 sequences (17,18,57).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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